<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37502886</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Associations between COVID-19 and putative markers of neuroinflammation: A diffusion basis spectrum imaging study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.07.20.549891</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.07.20.549891</ELocationID><Abstract><AbstractText>COVID-19 remains a significant international public health concern. Yet, the mechanisms through which symptomatology emerges remain poorly understood. While SARS-CoV-2 infection may induce prolonged inflammation within the central nervous system, the evidence primarily stems from limited small-scale case investigations. To address this gap, our study capitalized on longitudinal UK Biobank neuroimaging data acquired prior to and following COVID-19 testing (N=416 including n=224 COVID-19 cases; M<sub>age</sub>=58.6). Putative neuroinflammation was assessed in gray matter structures and white matter tracts using non-invasive Diffusion Basis Spectrum Imaging (DBSI), which estimates inflammation-related cellularity (DBSI-restricted fraction; DBSI-RF) and vasogenic edema (DBSI-hindered fraction; DBSI-HF).We hypothesized that COVID-19 case status would be associated with increases in DBSI markers after accounting for potential confound (age, sex, race, body mass index, smoking frequency, and data acquisition interval) and multiple testing. COVID-19 case status was not significantly associated with DBSI-RF (|&#x3b2;|'s&lt;0.28, p<sub>FDR</sub> &gt;0.05), but with greater DBSI-HF in left pre- and post-central gyri and right middle frontal gyrus (&#x3b2;'s&gt;0.3, all p<sub>FDR</sub>=0.03). Intriguingly, the brain areas exhibiting increased putative vasogenic edema had previously been linked to COVID-19-related functional and structural alterations, whereas brain regions displaying subtle differences in cellularity between COVID-19 cases and controls included regions within or functionally connected to the olfactory network, which has been implicated in COVID-19 psychopathology. Nevertheless, our study might not have captured acute and transitory neuroinflammatory effects linked to SARS-CoV-2 infection, possibly due to symptom resolution before the imaging scan. Future research is warranted to explore the potential time- and symptom-dependent neuroinflammatory relationship with COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-6428-2033</Identifier><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorelik</LastName><ForeName>Aaron J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-2589-1220</Identifier><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>Sara A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hershey</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Arpana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bijsterbosch</LastName><ForeName>Janine D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogdan</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG061162</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AA027827</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS109487</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DA055367</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK126826</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD070855</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA054750</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH128286</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Brain Behav Immun Health. 2023 Dec 30;36:100722. doi: 10.1016/j.bbih.2023.100722</RefSource><PMID Version="1">38298902</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DBSI</Keyword><Keyword MajorTopicYN="N">Diffusion Basis Spectrum Imaging</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">UK Biobank</Keyword><Keyword MajorTopicYN="N">neuroimaging</Keyword></KeywordList><CoiStatement>Conflict of Interest Statement The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37502886</ArticleId><ArticleId IdType="pmc">PMC10370178</ArticleId><ArticleId IdType="doi">10.1101/2023.07.20.549891</ArticleId><ArticleId IdType="pii">2023.07.20.549891</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akinbami LJ. SARS-CoV-2 Serology and Self-Reported Infection Among Adults &#x2014; National Health and Nutrition Examination Survey, United States, August 2021&#x2013;May 2022. MMWR Morb Mortal Wkly Rep [Internet]. 2022.  [cited
2023 Jun 20];71. Available from: https://www.cdc.gov/mmwr/volumes/71/wr/mm7148a4.htm</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9721142</ArticleId><ArticleId IdType="pubmed">36454698</ArticleId></ArticleIdList></Reference><Reference><Citation>Baj J, Karaku&#x142;a-Juchnowicz H, Teresi&#x144;ski G, Buszewicz G, Ciesielka M, Sitarz R, et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020. Jun 5;9(6):1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7356953</ArticleId><ArticleId IdType="pubmed">32516940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022. Jun 3;19(11):6865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9180091</ArticleId><ArticleId IdType="pubmed">35682448</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022. Feb;23(2):194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasco EE, Dukes K, Jones D, Comellas AP, Hoffman RM, Garg A. Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID. Int J Environ Res Public Health. 2022. Nov 23;19(23):15499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9737348</ArticleId><ArticleId IdType="pubmed">36497573</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022. Mar 15;434:120162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseer S, Khalid S, Parveen S, Abbass K, Song H, Achim MV. COVID-19 outbreak: Impact on global economy. Front Public Health. 2022;10:1009393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923118</ArticleId><ArticleId IdType="pubmed">36793360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler David M. The Economic Cost of Long COVID: An Update [Internet]. [cited
2023 Aug 28]. Available from: https://scholar.harvard.edu/files/cutler/files/long_covid_update_7-22.pdf</Citation></Reference><Reference><Citation>Cutler DM. The Costs of Long COVID. JAMA Health Forum. 2022. May 12;3(5):e221809.</Citation><ArticleIdList><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Isasi F, Naylor MD, Skorton D, Grabowski DC, Hern&#xe1;ndez S, Rice VM. Patients, Families, and Communities COVID-19 Impact Assessment: Lessons Learned and Compelling Needs. NAM Perspect. 2021:10.31478/202111c.</Citation><ArticleIdList><ArticleId IdType="doi">10.31478/202111c</ArticleId><ArticleId IdType="pmc">PMC8803391</ArticleId><ArticleId IdType="pubmed">35118349</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. Journal of Medical Virology. 2022;94(1):253&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons N, Outsikas A, Parish A, Clohesy R, D&#x2019;Aprano F, Toomey F, et al. Modelling the Anatomic Distribution of Neurologic Events in Patients with COVID-19: A Systematic Review of MRI Findings. AJNR Am J Neuroradiol. 2021. Jul;42(7):1190&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324279</ArticleId><ArticleId IdType="pubmed">33888458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, et al. Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study. EClinicalMedicine. 2020. Aug;25:100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar PR, Shilpa B, Jha RK. Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brain. Neurosci Biobehav Rev. 2023. Jun;149:105150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10063523</ArticleId><ArticleId IdType="pubmed">37004892</ArticleId></ArticleIdList></Reference><Reference><Citation>Radmanesh A, Derman A, Lui YW, Raz E, Loh JP, Hagiwara M, et al. COVID-19&#x2013;associated Diffuse Leukoencephalopathy and Microhemorrhages. Radiology. 2020. Oct;297(1):E223&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507998</ArticleId><ArticleId IdType="pubmed">32437314</ArticleId></ArticleIdList></Reference><Reference><Citation>Du YY, Zhao W, Zhou XL, Zeng M, Yang DH, Xie XZ, et al. Survivors of COVID-19 exhibit altered amplitudes of low frequency fluctuation in the brain: a resting-state functional magnetic resonance imaging study at 1-year follow-up. Neural Regeneration Research. 2022. Jul;17(7):1576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8771089</ArticleId><ArticleId IdType="pubmed">34916443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021. May 7;144(4):1263&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021. Feb;48(2):592&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill NW, Roudaia E, Chen JJ, Gilboa A, Sekuler A, Ji X, et al. Effects of post-acute COVID-19 syndrome on the functional brain networks of non-hospitalized individuals. Front Neurol. 2023;14:1136408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083436</ArticleId><ArticleId IdType="pubmed">37051059</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rau A, Schroeter N, Blazhenets G, Dressing A, Walter LI, Kellner E, et al. Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain. 2022. Sep 14;145(9):3203&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214163</ArticleId><ArticleId IdType="pubmed">35675908</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J, Lepra M, Kish SJ, Rusjan Pablo M, Nasser Z, Verhoeff N, et al. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms. JAMA Psychiatry [Internet]. 2023. May 31 [cited 2023 Jul 5]; Available from: 10.1001/jamapsychiatry.2023.1321</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1321</ArticleId><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021. May;94:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Zhou Z, Yang D, Zhao W, Zeng M, Xie X, et al. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain. 2021. Dec 16;145(5):1830&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8754808</ArticleId><ArticleId IdType="pubmed">34918020</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Zhou X, Zhao W, Du Y, Yang D, Huang Y, et al. Dynamic white matter changes in recovered COVID-19 patients: a two-year follow-up study. Theranostics. 2023. Jan 1;13(2):724&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9830428</ArticleId><ArticleId IdType="pubmed">36632218</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020. Jun;20(6):355&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Darif D, Hammi I, Kihel A, El Idrissi Saik I, Guessous F, Akarid K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb Pathog. 2021. Apr;153:104799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889464</ArticleId><ArticleId IdType="pubmed">33609650</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, et al. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines (Basel). 2021. Apr 29;9(5):436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145892</ArticleId><ArticleId IdType="pubmed">33946736</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Frontiers in Immunology [Internet]. 2020.  [cited
2023 Jun 24];11. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2020.01446</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01446</ArticleId><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021. Feb;24(2):168&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M, et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports. 2022. Feb 8;17(2):307&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Simr&#xe9;n J, Ed&#xe9;n A, Andersson LM, Nilsson S, Ashton NJ, et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021. Jul 29;70:103512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Current Opinion in Neurobiology. 2022. Oct 1;76:102608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239981</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A, et al. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurology. 2020. Jun 18;20(1):248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301053</ArticleId><ArticleId IdType="pubmed">32552792</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser D, Golla SSV, Verfaillie SCJ, Coomans EM, Rikken RM, van de Giessen EM, et al.
Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET [Internet]. medRxiv; 2022.  [cited
2023 Jun 20]. p. 2022.06.02.22275916.
Available from: https://www.medrxiv.org/content/10.1101/2022.06.02.22275916v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.02.22275916v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Science Translational Medicine. 2022. Jun 7;14(664):eabq3059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021. Jul;595(7868):565&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippens IHCHM, B&#xf6;sz&#xf6;rm&#xe9;nyi KP, Wubben JA, Fagrouch ZC, van Driel N, Mayenburg AQ, et al.
SARS-CoV-2 causes brain inflammation and induces Lewy body formation in macaques [Internet]. bioRxiv; 2021.  [cited
2023 Jun 20]. p. 2021.02.23.432474.
Available from: https://www.biorxiv.org/content/10.1101/2021.02.23.432474v2</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.23.432474v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Wischmann J, Bartos LM, Brendel M, Albert NL, Forbrig R, Straube A, et al. Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report. J Neurol. 2023;270(6):2853&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10069725</ArticleId><ArticleId IdType="pubmed">37012466</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu J, et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat Neurosci. 2016. Nov;19(11):1523&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5086094</ArticleId><ArticleId IdType="pubmed">27643430</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang Q, Haldar JP, Yeh FC, Xie M, Sun P, et al. Quantification of increased cellularity during inflammatory demyelination. Brain. 2011. Dec 1;134(12):3590&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3235568</ArticleId><ArticleId IdType="pubmed">22171354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross AH, Song SK. &#x201c;A new imaging modality to non-invasively assess multiple sclerosis pathology.&#x201d; J Neuroimmunol. 2017. Mar 15;304:81&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316501</ArticleId><ArticleId IdType="pubmed">27773433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Cusick MF, Wang Y, Sun P, Libbey JE, Trinkaus K, et al. Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. NMR Biomed. 2014. Jul;27(7):843&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071074</ArticleId><ArticleId IdType="pubmed">24816651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Wang Q, Sun Z, Flores S, Hobbs DA, Franklin EE, et al. Initial Correlation Analysis of Diffusion Basis Spectrum Imaging of Alzheimer&#x2019;s Brain and Quantitative Histology. Alzheimer&#x2019;s &amp; Dementia. 2022;18(S6):e064265.</Citation></Reference><Reference><Citation>Wang Y, Sun P, Wang Q, Trinkaus K, Schmidt RE, Naismith RT, et al. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Brain. 2015. May;138(Pt 5):1223&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407189</ArticleId><ArticleId IdType="pubmed">25724201</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirani A, Sun P, Schmidt RE, Trinkaus K, Naismith RT, Song SK, et al. Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report. Mult Scler. 2019. Dec;25(14):1937&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7493817</ArticleId><ArticleId IdType="pubmed">29992856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z, George A, Wu AT, Niu X, Lin J, Adusumilli G, et al. Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions. Ann Clin Transl Neurol. 2020. May;7(5):695&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261762</ArticleId><ArticleId IdType="pubmed">32304291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly M, Raji CA, Yu GZ, Wang Q, Wang Y, Schindler SE, et al. Obesity and White Matter Neuroinflammation Related Edema in Alzheimer&#x2019;s Disease Dementia Biomarker Negative Cognitively Normal Individuals. J Alzheimers Dis. 2021;79(4):1801&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817782</ArticleId><ArticleId IdType="pubmed">33459647</ArticleId></ArticleIdList></Reference><Reference><Citation>Samara A, Murphy T, Strain J, Rutlin J, Sun P, Neyman O, et al.
Neuroinflammation and White Matter Alterations in Obesity Assessed by Diffusion Basis Spectrum Imaging. Frontiers in Human Neuroscience [Internet]. 2020.  [cited
2022 Nov 1];13. Available from: https://www.frontiersin.org/articles/10.3389/fnhum.2019.00464</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2019.00464</ArticleId><ArticleId IdType="pmc">PMC6971102</ArticleId><ArticleId IdType="pubmed">31992978</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain JF, Burdo TH, Song SK, Sun P, El-Ghazzawy O, Nelson B, et al. Diffusion Basis Spectrum Imaging Detects Ongoing Brain Inflammation in Virologically Well Controlled HIV+ Patients. J Acquir Immune Defic Syndr. 2017. Dec 1;76(4):423&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659935</ArticleId><ArticleId IdType="pubmed">28796748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Wang Y, Liu J, Sutphen CL, Cruchaga C, Blazey T, et al. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer&#x2019;s disease. Neuroimage Clin. 2019;22:101767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6428957</ArticleId><ArticleId IdType="pubmed">30901713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Rutlin J, Eisenstein SA, Wang Y, Barch D, Hershey T, et al.
Neuroinflammation in the amygdala is associated with recent depressive symptoms. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging [Internet]. 2023. 
May
9 [cited
2023 Jun 20]; Available from: https://www.sciencedirect.com/science/article/pii/S2451902223001192</Citation><ArticleIdList><ArticleId IdType="pubmed">37164312</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavasour I, Sun P, Graf C, Yik J, Kolind S, Li D, et al. Characterisation of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging. Mult Scler. 2022. Mar;28(3):418&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9665421</ArticleId><ArticleId IdType="pubmed">34132126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan J, Lin TH, Libbey JE, Sun P, Ye Z, Song C, et al. Diffusion Basis Spectrum and Diffusion Tensor Imaging Detect Hippocampal Inflammation and Dendritic Injury in a Virus-Induced Mouse Model of Epilepsy. Front Neurosci. 2018;12:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818459</ArticleId><ArticleId IdType="pubmed">29497358</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Sali&#xe9; H, Tanevski J, Killmer S, Lago MS, Schlaak AE, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021. Jul 13;54(7):1594&#x2013;1610.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirani A, Sun P, Trinkaus K, Perantie DC, George A, Naismith RT, et al. Diffusion basis spectrum imaging for identifying pathologies in MS subtypes. Ann Clin Transl Neurol. 2019. Nov;6(11):2323&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6856605</ArticleId><ArticleId IdType="pubmed">31588688</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLOS Medicine. 2015. Mar 31;12(3):e1001779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pines AR, Cieslak M, Larsen B, Baum GL, Cook PA, Adebimpe A, et al. Leveraging multi-shell diffusion for studies of brain development in youth and young adulthood. Dev Cogn Neurosci. 2020. Apr 22;43:100788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200217</ArticleId><ArticleId IdType="pubmed">32510347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasternak O, Shenton ME, Westin CF. Estimation of Extracellular Volume from Regularized Multi-Shell Diffusion MRI. Med Image Comput Comput Assist Interv. 2012;15(0 2):305&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039075</ArticleId><ArticleId IdType="pubmed">23286062</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeurissen B, Tournier JD, Dhollander T, Connelly A, Sijbers J. Multi-tissue constrained spherical deconvolution for improved analysis of multi-shell diffusion MRI data. Neuroimage. 2014. Dec;103:411&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25109526</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaro-Almagro F, Jenkinson M, Bangerter NK, Andersson JLR, Griffanti L, Douaud G, et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. NeuroImage. 2018. Feb 1;166:400&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770339</ArticleId><ArticleId IdType="pubmed">29079522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, George A, Perantie DC, Trinkaus K, Ye Z, Naismith RT, et al.
Diffusion basis spectrum imaging provides insights into MS pathology. Neurology - Neuroimmunology Neuroinflammation [Internet]. 2020. 
Mar
1 [cited
2022 Nov 1];7(2). Available from: https://nn.neurology.org/content/7/2/e655</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7011117</ArticleId><ArticleId IdType="pubmed">31871296</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Wu W, Xu H, Flores S, Hobbs DA, Perrin RJ, et al.
Imaging and quantifying microglial activation in vivo and ex vivo using diffusion MRI &#x2013; with validation by immunohistochemistry. In ALZ; 2023.  [cited
2023 Sep 6]. Available from: https://alz.confex.com/alz/2023/meetingapp.cgi/Paper/79302</Citation></Reference><Reference><Citation>Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl. 2006;96:444&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16671502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalby T, Wohl E, Dinsmore M, Unger Z, Chowdhury T, Venkatraghavan L. Pathophysiology of Cerebral Edema&#x2014;A Comprehensive Review. J Neuroanaesth Crit Care. 2021. Sep;08(3):163&#x2013;72.</Citation></Reference><Reference><Citation>Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain. Neuron. 2002. Jan 31;33(3):341&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832223</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, S&#xe9;gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006. Jul 1;31(3):968&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci. 2001. Aug 29;356(1412):1293&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1088516</ArticleId><ArticleId IdType="pubmed">11545704</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage. 2014. May 15;92(100):381&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010955</ArticleId><ArticleId IdType="pubmed">24530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009. Jan 1;44(1):83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantone D, Locci S, Bergantini L, Manco C, Cortese R, Meocci M, et al. Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations. J Neurol Neurosurg Psychiatry. 2022. Dec 1;93(12):1343&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137741</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L, Steardo L, Scuderi C. Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic. Neurochem Res. 2023. Apr;48(4):1015&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362636</ArticleId><ArticleId IdType="pubmed">35922744</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022. Nov 2;110(21):3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022. Jan 21;375(6578):267&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong GU, Lyu J, Kim KD, Chung YC, Yoon GY, Lee S, et al. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death. Microbiol Spectr. 2022. Jun 29;10(3):e0109122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9241873</ArticleId><ArticleId IdType="pubmed">35510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroujeni ME, Simani L, Bluyssen HAR, Samadikhah HR, Zamanlui Benisi S, Hassani S, et al. Inflammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19. ACS Chem Neurosci. 2021. Jun 16;12(12):2143&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">34100287</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Martins AJ, Lau WW, Rachmaninoff N, Chen J, Imberti L, et al. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell. 2021. Apr 1;184(7):1836&#x2013;1857.e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874909</ArticleId><ArticleId IdType="pubmed">33713619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouayed J, Bohn T. The link between microglia and the severity of COVID-19: The &#x201c;two-hit&#x201d; hypothesis. J Med Virol. 2021. Jul;93(7):4111&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250886</ArticleId><ArticleId IdType="pubmed">33788265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, et al. Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post&#x2013;COVID-19 Conditions. JAMA Psychiatry. 2022. Nov 1;79(11):1081&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Brusaferri L, Alshelh Z, Martins D, Kim M, Weerasekera A, Housman H, et al. The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic. Brain Behav Immun. 2022. May;102:89&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847082</ArticleId><ArticleId IdType="pubmed">35181440</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008. Aug;82(15):7264&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R, Bilinska K. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. ACS Chem Neurosci. 2020. May 6;11(9):1200&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32283006</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020. Jul 31;6(31):eabc5801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelle F, Iorio-Morin C, D&#x2019;amour S, Fortin D. Superior Longitudinal Fasciculus: A Review of the Anatomical Descriptions With Functional Correlates. Frontiers in Neurology [Internet]. 2022.  [cited
2023 Jun 26];13. Available from: https://www.frontiersin.org/articles/10.3389/fneur.2022.794618</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.794618</ArticleId><ArticleId IdType="pmc">PMC9093186</ArticleId><ArticleId IdType="pubmed">35572948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Pathak S, Stefaneanu L, Yeh FC, Li S, Fernandez-Miranda JC. Subcomponents and connectivity of the superior longitudinal fasciculus in the human brain. Brain Struct Funct. 2016. May 1;221(4):2075&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25782434</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M, N&#xe4;gele FL, Mayer C, Schell M, Petersen E, K&#xfc;hn S, et al. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2023. May 30;120(22):e2217232120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10235949</ArticleId><ArticleId IdType="pubmed">37220275</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bispo DDC, de Brand&#xe3;o PRP, Pereira DA, Maluf FB, Dias BA, Paranhos HR, et al. Brain microstructural changes and fatigue after COVID-19. Front Neurol. 2022. Nov 10;13:1029302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9685991</ArticleId><ArticleId IdType="pubmed">36438956</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020. Feb 15;395(10223):497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani Zangbar H, Gorji A, Ghadiri T. A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View. Mol Neurobiol. 2021. Feb 1;58(2):536&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519857</ArticleId><ArticleId IdType="pubmed">32981023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafali HY, Dasgin H, Sahin D, Sozan SS, Oguz KK, Mutlu M, et al. The effect of SARS-CoV-2 virus on resting-state functional connectivity during adolescence: Investigating brain correlates of psychotic-like experiences and SARS-CoV-2 related inflammation response. Psychiatry Research: Neuroimaging. 2023. Nov 5;111746.</Citation><ArticleIdList><ArticleId IdType="pubmed">37979347</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z, Tu Y, Calhoun VD, Zhang Y, Zhao Q, Chen J, et al. Dynamic functional network connectivity associated with post-traumatic stress symptoms in COVID-19 survivors. Neurobiology of Stress. 2021. Nov 1;15:100377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339567</ArticleId><ArticleId IdType="pubmed">34377750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Wei T, Liu X, Liu Y, Song W, Que X, et al. Causal effects of COVID-19 on structural changes in specific brain regions: a Mendelian randomization study. BMC Med. 2023. Jul 19;21(1):261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10354891</ArticleId><ArticleId IdType="pubmed">37468885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanabria-Diaz G, Etter MM, Melie-Garcia L, Lieb JM, Psychogios MN, Hutter G, et al. Brain cortical alterations in COVID-19 patients with neurological symptoms. Front Neurosci. 2022. Oct 20;16:992165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9630324</ArticleId><ArticleId IdType="pubmed">36340780</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker MB, Bues HF, Brusaferri L, Kim M, Saadi D, Ratai EM, et al. Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures. bioRxiv. 2023. Oct 20;2023.10.19.563117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11225883</ArticleId><ArticleId IdType="pubmed">38642615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infectious Diseases. 2022. May 7;22(1):439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9077344</ArticleId><ArticleId IdType="pubmed">35525973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhwani SK, Mirza T, Khatoon A, Shaikh F, Khan R, Shaikh OA, et al.
Inflammatory Markers and COVID-19 Disease Progression. J Infect Public Health [Internet]. 2023. 
Jun
26 [cited
2023 Sep 14]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290960/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290960</ArticleId><ArticleId IdType="pubmed">37442012</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao LN, Ran X, Zhong YX, Li SS. Clinical value of blood markers to assess the severity of coronavirus disease 2019. BMC Infectious Diseases. 2021. Sep 6;21(1):921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420143</ArticleId><ArticleId IdType="pubmed">34488665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahat RK, Panda S, Rathore V, Swain S, Yadav L, Sah SP. The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis. Clinical Epidemiology and Global Health. 2021. Jul 1;11:100727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7979575</ArticleId><ArticleId IdType="pubmed">33778183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S, Jagannathan P, Henrich TJ, Sherif ZA, Bime C, Quinlan E, et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). Iqbal J, Zaidi M, editors. eLife. 2023. May 26;12:e86014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Nguyen DC, Faliti CE, Saini AS, Lee FEH, Sanz I. Response under pressure: deploying emerging technologies to understand B-cell-mediated immunity in COVID-19. Nat Methods. 2022. Apr;19(4):387&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9703369</ArticleId><ArticleId IdType="pubmed">35396475</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017. Nov 1;186(9):1026&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860371</ArticleId><ArticleId IdType="pubmed">28641372</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>